Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is projected to have strong growth potential in both its Mobile Health Services and Transportation Services segments, particularly with the new virtual care and last-mile healthcare offerings. However, management may face challenges in scaling the business and achieving profitability in the short term. The company has also faced staffing shortages and related costs, which may impact its financials. While there is potential for growth in the long term, investors may want to monitor the company's progress and financials in the near term before considering an investment.

Bears say

DocGo is a company with potential in an emerging market but still has a lot of work to do in order to achieve sustainable growth. Challenges include slower-than-expected ramp-up of core payer/provider Mobile Health businesses, which are still struggling after the loss of a large, high-margin government contract. The company also needs to work on right sizing its cost structure and generating enough operating expense savings to achieve their adj-EBITDA target.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.